Shareholder Alert: Ademi LLP investigates whether Forma Therapeutics, Holdings Inc. has obtained a Fair Price in its transaction with Novo Nordisk

Provided By PR Newswire

Last update: Sep 1, 2022

MILWAUKEE, Sept. 1, 2022 /PRNewswire/ -- Ademi LLP is investigating Forma Therapeutics (NASDAQ: FMTX) for possible breaches of fiduciary duty and other violations of law in its transaction with Novo Nordisk.